Updated FDA Statement on Compounded Versions of hydroxyprogesterone caproate (the active ingredient in Makena)

by FDA on June 15, 2012

in FDA Alerts

Updated FDA Statement on Compounded Versions of hydroxyprogesterone caproate (the active ingredient in Makena)

This is a summary of a Press Release issued by the Food and Drug Administration (FDA). The link below will take you to the original press release containing complete information, including instructions about what to do if you are affected.

View Full Details Of Original FDA Press Release Here.

Leave a Comment

Previous post:

Next post: